Formulation and Drug Delivery

US Leads the Way for Drug Device Innovation but Lags Behind for Sustainability, Notes Pharmapack 2021 Report

September 24, 2021

The organizers of Pharmapack Europe have released the results of its global drug delivery and packaging survey, demonstrating the continuation of the United States’ lead in innovation.

Celsion and Poly Pharm to Manufacture Celsion’s DNA-Based Vaccine

September 23, 2021

In an amendment to their existing contract manufacturing agreement, Celsian and Poly Pharm expand GEN-1 program collaboration to add clinical and commercial batches of investigational vaccine.

Real-World Evidence Shows Strong Protection from COVID-19 with J&J Vaccine and Booster

September 23, 2021

New data finds J&J COVID-19 vaccine and booster to provide increased protection against COVID-19.

FDA Approves Biosimilar for Treatment of Eye Disease

September 21, 2021

The agency approved Byooviz (ranibizumab-nuna), a biosimilar to Lucentis (ranibizumab injection), for the treatment of several eye diseases.

Pfizer and BioNTech Announce Positive Results In COVID-19 Vaccine Trial for Children Ages 5 to 11

September 21, 2021

The topline data from Pfizer and BioNTech’s trial suggests that a 10 µg vaccine is safe and effective among the 5 to 11 age group.

Vaccine Booster Battle Reveals Rifts Among Regulators and Sponsors

September 20, 2021

FDA advisors agreed unanimously on a more limited booster plan after rejecting Pfizer’s original request to authorize its third shot for everyone over age 16.

Moderna Releases New Clinical Data on COVID-19 Vaccine

September 17, 2021

Moderna’s newest insights include an overall efficacy review, a study on breakthrough infections, and a study on long-term immunity.

Considering Titanium Dioxide Regulatory Changes

September 16, 2021

EFSA’s evaluation of risk in food products raises implications for drug product formulations.

Best Practices in Manufacturing Inhalation Drugs

September 13, 2021

When designing and manufacturing a pMDI or DPI combination drug-delivery device, the commercial stage should be kept in mind from the beginning of development.

Biden Bolsters Vaccine Production in Pandemic Preparedness Plan

September 10, 2021

The White House announced a nearly $3 billion program to ramp up production of vaccines and their components.